Paxlovid May Reduce Risk of Long Covid in Eligible Patients, Study Finds

Health
By BY PAM BELLUCK from NYT Health https://ift.tt/spU5djc
via IFTTT Long Covid, Paxlovid (Drug), Coronavirus (2019-nCoV), Chronic Condition (Health), Research, Electronic Health Records, Veterans, Disease Rates The research looked at patients who qualified for the antiviral through age or health conditions. Those who took it shortly after infection were 26 percent less likely to have symptoms 90 days later.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda